As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of GoodRx Holdings, Inc. The largest reported stake is Francisco Partners IV, L.P.'s, at 32.9%. 6 filings are on record since July 3, 2025 (Schedule 13D/A, August 26, 2026).
Sell to companies like GoodRx Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Francisco Partners IV, L.P. · Sole voting: 0 · Shared voting: 35,023,391 · Sole dispositive: 0 · Shared dispositive: 35,023,391 · SCHEDULE 13D/A, 2026-08-26
- · Holder: The Vanguard Group · Percent: 0% · SCHEDULE 13G/A
- · Holder: The Vanguard Group · Percent: 9.33% · SCHEDULE 13G/A
- · Holder: Spectrum Equity VII, L.P. · Percent: 0% · SCHEDULE 13D/A
- · Holder: Spectrum Equity VII, L.P. · Percent: 8.28% · SCHEDULE 13D/A
GoodRx Holdings, Inc. has 6 Schedule 13D or 13G filings on record since 2025-07-03. 1 holder's latest filing reports 5% or more of class a common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Francisco Partners IV, L.P. | 32.9% | 35,023,391 | SCHEDULE 13D/A, 2026-08-26 | 2026-08-19 |
| Spectrum Equity VII, L.P. | 0% | 0 | SCHEDULE 13D/A, 2025-10-16 | 2025-10-14 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind GoodRx Holdings, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on GoodRx Holdings, Inc. and the records around it.
GoodRx Holdings, Inc. elsewhere on the record
- Leadership changes Apr 2026
- Who owns it
Companies that share a holder
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch GoodRx Holdings, Inc.
Get an email when GoodRx Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on GoodRx Holdings, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on GoodRx Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GoodRx Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Francisco Partners IV, L.P. | 0 | 35,023,391 | 0 | 35,023,391 | SCHEDULE 13D/A, 2026-08-26 |
| Francisco Partners IV-A, L.P. | 0 | 17,554,793 | 0 | 17,554,793 | SCHEDULE 13D/A, 2026-08-26 |
| Francisco Partners GP IV, L.P. | 0 | 52,578,184 | 0 | 52,578,184 | SCHEDULE 13D/A, 2026-08-26 |
| Francisco Partners GP IV Management Limited | 0 | 52,578,184 | 0 | 52,578,184 | SCHEDULE 13D/A, 2026-08-26 |
| Francisco Partners Management, L.P. | 0 | 52,578,184 | 0 | 52,578,184 | SCHEDULE 13D/A, 2026-08-26 |
The latest filing identifies GoodRx Holdings, Inc. by CUSIP 38246G108 and gives its principal executive office as 2701 OLYMPIC BOULEVARD, SANTA MONICA, CA 90404 (SCHEDULE 13D/A, 2026-08-26).
Purpose of Transaction (Item 4)
Spectrum Equity VII, L.P.
Item 4 of the Schedule 13D is hereby amended to include the following at the end thereof: On October 14, 2025, SE VII distributed 8,881,362 shares of the Issuer's Class A Common Stock pro rata to its limited partners for no consideration (the "October 2025 Distribution"). Following the October 2025 Distribution, Spectrum VII Co-Investment Fund, L.P. and Spectrum VII Investment Managers' Fund, L.P. made open market sales of an aggregate of 23,771 shares of the Issuer's Class A Common Stock for net proceeds of $95,103.02 (such sales, the "October 2025 Sales").Item 4 of the SCHEDULE 13D/A filed 2025-10-16
Francisco Partners IV, L.P.
Item 4 of the Original 13D is hereby amended to include the following at the end thereof: On August 20, 2026, Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. converted 4,995,903 and 2,504,097 Class B Shares to Class A Shares and distributed in kind 3,596,648 and 1,142,357 Class A Shares, respectively, to their respective general partner and limited partners, and each such general partner in turn distributed such Class A Shares to its ultimate direct or indirect partners (such distributing entity the "FP Entities" and the "August 2026 Francisco Partners Distribution"), in each case, pro rata and for no consideration. In addition, on such date, the remaining 2,743,043 Class A Shares received upon such conversion were sold by the FP Entities for an aggregate consideration of $9,678,731.4997, which proceeds were distributed to their respective partners.Item 4 of the SCHEDULE 13D/A filed 2026-08-26
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-03 | Spectrum Equity VII, L.P. | 12.9% | SCHEDULE 13D/A |
| 2025-09-08 | Spectrum Equity VII, L.P. | 8.28% | SCHEDULE 13D/A |
| 2025-10-16 | Spectrum Equity VII, L.P. | 0% | SCHEDULE 13D/A |
| 2025-10-30 | The Vanguard Group | 9.33% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-08-26 | Francisco Partners IV, L.P. | 32.9% | SCHEDULE 13D/A |
Questions about who owns GoodRx Holdings, Inc.
Who owns GoodRx Holdings, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of GoodRx Holdings, Inc.: Francisco Partners IV, L.P. (32.9%, Schedule 13D/A, filed 2026-08-26).
When did Francisco Partners IV, L.P. buy into GoodRx Holdings, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Francisco Partners IV, L.P. on this page is the Schedule 13D/A, filed 2026-08-26, reporting 32.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for GoodRx Holdings, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 24, 2026 | Leadership change: Thomas Chan appointed, Chief Accounting Officer | — | Leadership changes | Source |
| April 3, 2026 | Leadership change: Ian T. Clark departs | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for GoodRx Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.